Skip to main content

Advertisement

Log in

Intratumoral induction of tumour necrosis factor by systemic administration of Bordetella pertussis vaccine

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Intratumoral induction of tumour necrosis factor (TNF) by administration of Bordetella pertussis vaccine (BPV) as compared with that by the agent OK-432 was investigated in mice. Two hours after such administration tumour tissues tested were resected from the mice, homogenised, and the TNF activities in the homogenate were assayed using a L-929 fibroblast assay. Intravenous injection of BPV into mice bearing the MM46 carcinoma resulted in a greater concentration of TNF in the tumour homogenate than in the serum. With OK-432, however, there was a greater concentration of TNF in the serum than in the tumour homogenates. A high level of intratumoral TNF induction by BPV was also observed in mice bearing Meth A fibrosarcoma or Lewis lung carcinoma. The therapeutic effect against the Meth A fibrosarcoma was in parallel with the intratumoral TNF activity. Intratumoral TNF activity is therefore believed to be a good index of therapeutic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Minagawa, H., Kobayashi, H., Yoshida, H. et al. Intratumoral induction of tumour necrosis factor by systemic administration of Bordetella pertussis vaccine. Br J Cancer 62, 372–375 (1990). https://doi.org/10.1038/bjc.1990.300

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1990.300

  • Springer Nature Limited

Navigation